Jin Rong Jie·2025-08-21 16:29Group 1 - The core viewpoint of the article highlights that 康龙化成's stock price increased by 0.40% to 30.01 yuan as of August 21, 2025, with a trading volume of 336,003 hands and a transaction amount of 1.009 billion yuan [1] - 康龙化成 operates in the medical services sector, providing drug research outsourcing services, including drug discovery and preclinical and clinical research services for global pharmaceutical companies [1] - The company reported a revenue of 6.441 billion yuan for the first half of 2025, representing a year-on-year growth of 14.93%, while the net profit attributable to shareholders decreased by 37% to 701 million yuan, primarily due to significant investment gains from the disposal of PROTEOLOGIX, INC. in the previous year [1] Group 2 - On August 21, 2025, the net outflow of main funds was 75.8173 million yuan, with a cumulative net outflow of 302.7646 million yuan over the past five days [1]